Standout Papers

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal ... 2007 2026 2013 2019 517
  1. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets (2007)
    Uwe Rix, Oliver Hantschel et al. Blood
  2. Target profiling of small molecules by chemical proteomics (2008)
    Uwe Rix, Giulio Superti‐Furga Nature Chemical Biology

Immediate Impact

9 by Nobel laureates 32 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Computational approaches streamlining drug discovery
2023 StandoutNature
Targeting CDK4 and CDK6 in cancer
2022 Standout
2 intermediate papers

Works of Uwe Rix being referenced

Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer
2015
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets
2007 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Uwe Rix 2585 1022 883 88 4.8k
Pascal Furet 5496 2324 1059 125 8.5k
Markus Wartmann 3740 2130 373 89 6.8k
William P. Tong 3543 2030 475 109 6.5k
Gÿorgý Kéri 3423 1682 475 160 6.0k
Markus A. Seeliger 3017 781 746 73 4.4k
Pramod S. Pandey 5250 1171 855 95 7.2k
Raymond J. Hohl 2256 1513 606 138 4.8k
Arianna Donella‐Deana 2205 721 503 91 3.7k
Peter Traxler 2593 1543 351 60 4.5k
Rosanna Supino 2984 1736 476 109 4.9k

All Works

Loading papers...

Rankless by CCL
2026